Development of a new treatment for CNS demyelinating disorders targeting glucose and monocarboxylate transporter
Development of a new treatment for CNS demyelinating disorders targeting glucose and monocarboxylate transporter
批准号:
17K16124
负责人:
Watanabe Mitsuru
金额:
$2.66万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Young Scientists (B)
财政年份:
2017
资助国家:
日本
项目状态:
已结题
起止时间:
2017-04-01 至 2019-03-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Serum glial fibrillary acidic protein (GFAP) and neurofilament light chain (NfL) as potential biomarkers for disease activity and disability in neuromyelitis optica spectrum disorders and multiple sclerosis
血清胶质纤维酸性蛋白 (GFAP) 和神经丝轻链 (NfL) 作为视神经脊髓炎谱系疾病和多发性硬化症疾病活动性和残疾的潜在生物标志物
DOI:
--
发表时间:
2018
期刊:
影响因子:
--
作者:
[Watanabe M, et al.]
通讯作者:
et al.
Development of organic-inorganic hybrid diodes using electrochemical deposition
-
批准号:17K05853
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.16万
-
财政年份:2017
-
负责人:Watanabe Mitsuru
-
依托单位:
Development of a novel treatment strategy based on the mechanisms that pathogenic T cells induce loss of glial connexins in CNS demyelinating disorders
-
批准号:15K19489
-
项目类别:Grant-in-Aid for Young Scientists (B)
-
资助金额:$2.5万
-
财政年份:2015
-
负责人:Watanabe Mitsuru
-
依托单位:
海外基金